Galectin 3 (recombinant)

Added to your cart

Galectin 3 (recombinant)

Cart subtotal: £0.00

View cart (0) Checkout

#SKU P734-1


Price excludes shipping costs.
To view our shipping costs click here.

Need to order this product in bulk?

Contact our team of experts to discuss your bulk requirements

Contact our expert team

Product Details

Galectin-3 belongs to the lectin family and is a carbohydrate binding protein. It is predominantly expressed in the colonic and intestinal epithelium. It is also found in the activated macrophages, fibroblasts, tumor cells. The marker is associated with cancer, inflammation and fibrosis, heart disease and stroke. There are various research papers which have suggested different uses of Galectin-3 as a diagnostic marker; a pre-surgical marker for thyroid carcinoma, cell proliferation stimulant, differentiation of benign and malignant thyroid neoplasms, analysis of colorectal cancer progression and Crohns disease. It also has the ability to chemo attract human blood monocytes and macrophages.


More information



  • Shipping Information
  • Dry Ice
  • Abbreviations
  • Gal-3
  • Specification
  • ˃ 96%
  • Recommended Use
  • Research and further manufacturing
  • Storage
  • Below -15°C
  • Buffer
  • lyophilised from 0.02M NH4HCO3
  • Presentation Matrix
  • Single homogenous batch, supplied lyophilised from 0.02M NH4HCO3. May contain traces of buffer salts
  • Purity/grade
  • >96%
  • Source
  • Expressed in E.coli
  • Molecular weight
  • 26kDa
  • Uniprot No.
  • P17931

Technical Documents

Certificates Of Analysis (163.79KB)

Sorry, no results found.

Enter the full lot number and hit enter.

BBI Solutions Brands


The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.


Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.


Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox